Literature DB >> 32690652

Osteal Tissue Macrophages Are Involved in Endplate Osteosclerosis through the OSM-STAT3/YAP1 Signaling Axis in Modic Changes.

Jiasheng Wang1, Zeyu Zheng1, Bao Huang1, Hao Wu1, Xuyang Zhang1, Yilei Chen1, Junhui Liu1, Zhi Shan1, Shunwu Fan1, Jian Chen2, Fengdong Zhao2.   

Abstract

Modic changes (MCs) are radiographic manifestations of lumbar degenerative diseases. Various types of MCs are often associated with endplate osteosclerosis. Osteal tissue macrophages (Osteomacs) were reported to be crucial for bone homeostasis and bone repair, but whether osteomacs participate in the endplate osteosclerosis in MCs remained unclear. In this study, we tried to explore the critical role of osteomacs in regulating osteogenesis in MCs. We collected MCs from patient samples and developed a Propionibacterium acnes-induced rat MCs model, using microcomputed tomography and immunohistochemistry to detect the endplate bone mass and distribution of osteomacs. In patients' MCs, osteomacs increased in endplate subchondral bone, especially in Modic type II. Endplate in Modic type III presented a stable osteosclerosis. In rat MCs model, osteomacs increased in the bone hyperplasia area but not in the inflammation area of the endplate region, whereas the distribution of osteomacs was consistent with the area of osteosclerosis. To further explore the functions of osteomacs in vitro, we isolated osteomacs using MACS technology and found osteomacs secreted oncostatin M (OSM) and strongly promoted osteoblast differentiation rather than osteoclast through the mechanism of OSM-mediated tyrosine phosphorylation and interaction of STAT3 and Yes-associated protein 1 (YAP1). STAT3 phosphorylation inhibition or YAP1 knockdown attenuated OSM-mediated osteoblast differentiation. Finally, we confirmed that blockade of OSM in vivo using anti-OSM-neutralizing Ab prevented endplate osteosclerosis in rat MCs model. Taken together, these findings confirmed that endplate osteosclerosis in MCs was accompanied by an increased number of osteomacs, which regulated osteogenesis via the OSM-STAT3/YAP1 signaling axis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32690652     DOI: 10.4049/jimmunol.1901001

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.

Authors:  Kavita Bisht; Crystal McGirr; Seo-Youn Lee; Hsu-Wen Tseng; Whitney Fleming; Kylie A Alexander; Taichi Matsumoto; Valérie Barbier; Natalie A Sims; Gerhard Müller-Newen; Ingrid G Winkler; Halvard Bonig; Jean-Pierre Lévesque
Journal:  Leukemia       Date:  2021-09-13       Impact factor: 11.528

Review 2.  Communications Between Bone Marrow Macrophages and Bone Cells in Bone Remodeling.

Authors:  Kaixuan Chen; Yurui Jiao; Ling Liu; Mei Huang; Chen He; Wenzhen He; Jing Hou; Mi Yang; Xianghang Luo; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2020-12-22

3.  Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus.

Authors:  Shohei Ikeda; Koichi Sato; Morihiko Takeda; Keita Miki; Kentaro Aizawa; Tsuyoshi Takada; Koji Fukuda; Nobuyuki Shiba
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.